Intact Vascular says it raised a $39 million Series B round it plans to use to get its Tack peripheral artery disease treatment through the FDA.
Intact Vascular said it brought in a $38.9 million Series B round it plans to use to get its Tack endovascular device through the FDA approval process.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1ICUqM1
Cap comentari:
Publica un comentari a l'entrada